Dr. N. Kalyanam., President R & D along with his research group at Sabinsa’s Princeton R & D lab, developed a simplified cost effective and affordable manufacturing process for eflornithine, a drug used to fight African sleeping sickness.
Sabinsa Corporation is working in collaboration with the WHO on this project, contributing to the organization’s efforts to combat the parasitic disease that has resurged in epidemic proportions in certain parts of Africa.
A patent application for this process was recently submitted to the United States Patent and Trademark Office.
